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Available online 17 July 2016Introduction: There is growing evidence for natural recovery from cannabis use by people with psychosis, but
mechanisms underpinning it need further exploration. This study prospectively explored this issue.
Method: Twenty-two people with psychosis and cannabis misuse were recruited: 19 provided data for at least
one follow-up assessment, and 13 of these (68%) reduced or ceased using cannabis. A semi-structured interview
with the latter group explored reasons for initiating the attempt, strategies they employed, and context/s where
any relapse occurred. Interpretative phenomenological analysis was used to identify themes.
Results: Participants who reduced or ceased cannabis use had fewer negative symptoms at Baseline, and were
more likely to only use cannabis. Major reasons for starting an attempt were worsening mental health, relation-
ship and lifestyle difﬁculties. Effective strategies fell into psychological, relationship, lifestyle and medication
themes. Only three participants reported a relapse: triggers involved substance-using peers, relationship difﬁcul-
ties, and problems with negative emotions including ones from past trauma.
Conclusions:An encouragingly high rate ofmaintained reductions in cannabis usewas seen. Increased awareness
of the beneﬁts across multiple life domains from addressing cannabis use may be critical to the initiation and
maintenance of attempts, both to maximise motivation, and avoid over-dependence on improvements in any
single domain. Negative symptoms, multiple substance use, dysphoria and pressure from substance-using
peers clearly offer additional challenges for control.
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Natural recovery1. Introduction
Up to 80% of people with psychosis report cannabis use, which has
been associated with a range of adverse psychological, social, and phys-
ical health outcomes (Hjorthøj, Fohlmann, & Nordentoft, 2009; van der
Meer, Velthorst, & Generic Risk and Outcome of Psychosis (GROUP)
Investigators, 2015). Clinical trials of psychological treatments for
cannabis use in people with psychosis have not consistently reported
better outcomes than control conditions (Hjorthøj et al., 2009;
Rebgetz, Kavanagh, & Hides, 2015). This indicates that some people
with psychosis cease or reduce using cannabis with little or no related
treatment (Childs, McCarthy-Jones, Rowse, & Turpin, 2011; Lobbana et
al., 2010). An increased understanding of such ‘natural recovery’ could
be used to strengthen current treatments.
In a recent review, we found people with psychosis had similar rea-
sons for reducing substance use to those reported in the general popu-
lation (Rebgetz, Kavanagh, et al., 2015). Any differences in these
reasons were related to the presence of the psychotic disorder (e.g.cked Mail Bag 3, Caboolture,
ebgetz).
r B.V. This is an open access article usymptom exacerbation) and the ampliﬁed functional problems (e.g.
homelessness) that occur when someone with psychosis also misuses
a psychoactive substance. However, only eight studies have examined
the subjective experience of ceasing or reducing cannabis among indi-
viduals with psychosis (Rebgetz, Hides, Kavanagh, & Choudhary, 2015;
Rebgetz, Kavanagh, et al., 2015), and there is little examination ofmech-
anisms underpinning the phenomenon.
Qualitative methods have begun to provide additional insights into
the strategies used by this population. Our recent study found that ces-
sation was linked to the individual's awareness of themultiple negative
consequences of cannabis use or a more speciﬁc motivator (e.g., loss of
employment; Rebgetz, Hides, et al., 2015). Maintenance strategies were
associated with the awareness of the impact of cannabis use on mental
health symptoms, thinking about incentives and support from others.
Reasons for relapse were found to be similar to non-psychotic groups
including pressure from others, stressful events, coping with cravings
and boredom (Rebgetz, Hides, et al., 2015).
The retrospective nature of the qualitative studies that have ex-
plored recovery from cannabis use increases the risk of recall bias. The
current study prospectively explored factors inﬂuencing the decision
to cease and maintain cannabis cessation over a 3-month period
among people with early psychosis. Change strategies and the relapsender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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also explored.
2. Materials and methods
2.1. Participants
Participants were recruited from adult mental health services in the
Metro-North Health Service District in Brisbane. They were required to
(i) have a current diagnosis of a psychotic disorder (e.g., schizophrenia,
schizophreniform disorder, schizoaffective disorder, psychotic disorder
NOS); (ii) be in early stages of psychosis (less than three psychotic epi-
sodes measured on a Timeline Followback or medical record) and (iii)
have used cannabis in the previous 4 weeks. Participants were required
to be able to read and speak English without translation. Exclusion
criteria were a primary diagnosis of organic psychosis or psychosis
due to a general medical condition, intellectual disability, or a develop-
mental or amnestic disorder.
2.2. Data collection
2.2.1. Demographic and clinical data
Demographic and clinical data included gender, age at interview,
years of education, employment and relationship status, ethnicity, living
arrangement at interview, current diagnosis, medication, family history
of mental illness, psychiatric and cannabis treatment history.
2.2.2. Psychosis and symptoms
The Operational Criteria Checklist (OPCRIT; McGufﬁn, Farmer, &
Harvey, 1991) was used to conﬁrm the presence of a current psychotic
disorder, based on the medical record. Psychiatric symptoms were
monitored using the Brief Psychiatric Rating Scale (BPRS; Overall &
Gorham, 1962). BPRS positive, negative and depression-anxiety sub-
scale scores were derived at Baseline only (Ventura, Nuechterlein,
Subotnik, Gutkind, & Gilbert, 2000). BPRS items that did not require in-
terviewer observation were included in telephone interviews during
follow-up.
2.2.3. Cannabis use
Consumption of cannabis and other substances in the preceding
4 weeks was retrospectively assessed using a Timeline Followback
(TLFB; Sobell & Sobell, 1992), in which recollections of past events
were used to cue recall of substance use. Participants were also given
a calendar to mark the days they smoked cannabis over the month be-
tween follow-up assessments.
2.2.4. Semi-structured interviews
If participants had ceased or reduced use since the previous assess-
ment (indexed by ≥50% reduction in quantity), they were asked when
this occurred, what was happening in their lives, why it occurred, any
times it was hard to stay in control and how they did so. If they went
back to using, they were asked what was happening and what led
them to going back to using. If relapsing participants subsequently
attempted to regain control of their cannabis use, the interviewprotocol
included questions about themethods they used to do that. The qualita-
tive interviews lasted approximately 60–70 min long.
2.3. Procedure
Participants were referred to the study by their treating team. The
principal service provider gave potential participants oral and written
information about the research project and asked if they would like to
participate. The lead author then met with the potential participants
to obtain informed consent, which included information about the as-
sessment process. At Baseline, demographic data was obtained, and
the OPCRIT, BPRS and TLFB were administered. Monthly telephonefollow-up assessments were conducted using the BPRS and TLFB. Each
participant was provided with a calendar to assist with the completion
of the TLFB. They were asked to record days they used cannabis and
other substances aswell as informationon anymental health symptoms
they experienced during the month. The qualitative interviews were
undertaken during this phone call. Participants were reimbursed $10
at Baseline, $15 at Month 1, $20 at Month 2 and $30 at Month 3. Ethical
approval to conduct the study was obtained from the Brisbane Metro
South andQueenslandUniversity of TechnologyHuman Research Ethics
Committees (HREC/12/QPAH/606).
2.4. Design
Participants were assessed at baseline, and attempts were made to
follow them upmonthly to 3months. Thosewho had ceased or reduced
their cannabis consumption during the previous month (indexed by
≥50% reduction in quantity from baseline levels) were asked the quali-
tative questions. Table 1 provides an overview of each participant's can-
nabis use and participation in qualitative interviews over the course of
the study.
2.5. Qualitative analysis
Interviews were transcribed by the ﬁrst author, and were then
analysed using interpretative phenomenological analysis (IPA; Smith
& Osborn, 2003). The ﬁrst interview was reorganised and interpreted
to identify preliminary themes and patterns,with a list of representative
quotations illustrating each theme compiled. This procedure was re-
peated for each remaining interview, resulting in the identiﬁcation of
new themes. The identiﬁcation of themes for each research question
was completed separately. To ensure transparency and reliability, all
transcripts were reread and coded by at least one other member of
the research team. Coding and interpretations of the transcripts were
discussed by all authors in detail until consensus was reached on the
key themes. This approach allowed inconsistencies to be debated, and
themes to be reﬁned (Lobbana et al., 2010). Interconnections between
interviews were examined, and a list of master themes constructed. Se-
lection ofmaster themeswas based both on the frequency or “represen-
tativeness” of speciﬁc themes and on the richness of the theme within
an individual's account (Smith & Osborn, 2003). Since all authors had
training in cognitive behavioural therapy (CBT) and motivational
interviewing (MI), potential related biases in the interpretation of re-
sponses were discussed.
3. Results
3.1. Participant characteristics
Twenty-two participants consented to take part in the study: 19 of
these (86%) provided at least 1 month of follow-up data, and 16 (73%)
completed all 3 months of assessments. Five of those who dropped
out of the study were lost to contact by the researcher and the health
service, and the remaining participant withdrew because of work com-
mitments. There were no demographic or clinical differences between
those who completed the study and those who dropped out of the fol-
low-up assessments.
All participants were inpatients at the time of the baseline assess-
ment, and were community patients at each follow-up point. All were
prescribed antipsychotic medication while an inpatient, with 16 partic-
ipants being prescribed paliperidone 100 mg. Only two participants re-
ported receiving any previous cannabis use treatment and all were
receiving mental health support. No participants said that they had re-
ceived substance use treatment during the study, and only one partici-
pants ﬁle mentioned receiving psychoeducation for psychosis and
cannabis use.
Table 1
Participation and cannabis use.
Participant Baseline 1 month 2 months 3 months
THC use THC use Qualitative interview THC use Qualitative interview THC use Qualitative interview
1 Yes No – A √ No – A √ No - A √
2 Yes Yes - R – No - A √ No - A √
3 Yes No - A √ No - A √ No - A √
4 Yes Yes - U – Yes - U – Yes - U –
5 Yes No- A √ …a … … …
6 Yes Yes - U – Yes - U – Yes - U –
7 Yes No - A √ No - A √ …a …
8 Yes …a … … … … …
9 Yes Yes - U – Yes - U – Yes – U –
10 Yes Yes - U – Yes – R √ Yes - R √
11 Yes Yes - R √ No - A √ Yes – R √
12 Yes Yes - U – Yes - U – Yes – U –
13 Yes Yes - U – Yes - U – Yes – U –
14 Yes No - A √ No - A √ …a …
15 Yes Yes - U – Yes - U – Yes – U –
16 Yes Yes - U – Yes - U – No – A √
17 Yes Yes - R √ No - A √ Yes – R √
18 Yes No - A √ No - A √ No – A √
19 Yes …a … … … … …
20 Yes No - A √ Yes - R √ Yes – U –
21 Yes Yes - R √ No - A √ No - A √
22 Yes …a … … … … …
2. U - unchanged or higher consumption than at baseline.
3. R - reduced from baseline (by 50%).
4. A – abstinent.
a Lost to follow-up.
Table 2
Demographic, substance use and clinical characteristics of the patients who ceased/re-
duced cannabis consumption and did not cease/reduce cannabis use.
Reduction/cessation
Yes
(n= 13)
No
(n= 9)
p
Demographics
Age, M (SD) 25.8 (4.1) 23.9 (6.0) 0.38
Gender, male, N (%) 10 (77%) 6 (67%) 0.60
Employed, N (%) 5 (39%) 1 (11%) 0.11
Living arrangements, Live Alone, N (%) 0 (0)% 1 (11%) 0.12
Ethnicity, Australian born, non-Aboriginal, N (%) 11 (85%) 8 (89%) 0.68
Years of education, M (SD) 12 (1.6) 10.7 (1.3) 0.90
Relationship, single, N (%) 12 (92%) 6 (67%) 0.31
Clinical
First hospital admission, N (%) 8 (62%) 6 (67%) 0.81
Number of previous hospital admission, M (SD) 1.5 (0.8) 1.4 (0.7) 0.79
Prescribed medication, N (%) 13 (100%) 9 (100%) –
Family history of psychosis, N (%) 6 (46%) 2 (22%) 0.25
Family history of other mental illness, N (%) 5 (39%) 4 (44%) 0.78
Diagnosis, N (%) 0.21
Schizophrenia 5 (39%) 4 (44%)
Schizophreniform disorder 4 (31%) 4 (44%)
Substance-Induced – 1 (11%)
Schizoaffective disorder 4 (31%) –
Symptoms on BPRS
Total, M (SD) 44.6 (9.5) 47.8 (17.2) 0.82
Negative, M (SD) 7.5 (1.9) 5.7 (1.1) 0.01
Positive, M (SD) 10.0 (2.4) 12.0 (4.5) 0.32
Depression-anxiety, M (SD) 9.5 (4.8) 8.1 (3.7) 0.43
Manic-excitement, M (SD) 9.9 (3.5) 12.2 (9.2) 0.87
Substance use
Previous treatment, M (SD) 1 (8%) 1 (11%) 0.80
Days used cannabis, M (SD) 18.3 (6.7) 13.3 (5.3) 0.08
Cones per cannabis use day, M (SD) 5.0 (1.7) 3.8 (2.0) 0.01
Polysubstance use, N (%) 4 (31%) 9 (100%) 0.00
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bis consumption at somepoint assumed that the threewhoprovided no
follow-up data did not change their usage. Thosewho reported reduced
cannabis use were more likely to have only used cannabis (χ2(1, N =
22) = 7.8, p = 0.005) and had fewer BPRS negative symptoms
(rho= 0.55, n= 22, p b 0.01) at Baseline (see Table 2). There were no
other signiﬁcant differences between these groups.
One-way repeated measures ANOVAs assessed changes in cannabis
use and BPRS symptomsover each follow-up period. The 16participants
providing data to 3 months had a signiﬁcant reduction in the average
number of days cannabis was used in the preceding month (Baseline
M = 17.13, SD = 6.51; 3-month M = 7.56, SD = 7.39; F (3,13) =
6.61, p b 0.01), and in the amount of cannabis used per month than at
Baseline (Baseline M = 4.75, SD = 1.84; 3-month M = 1.88, SD =
1.82; F (3,13) = 8.91, p b 0.005). Signiﬁcant reductions on several
BPRS symptoms were also found: Emotional Withdrawal (from M =
2.00, SD = 0.97, to M = 1.38, SD = 0.81; F (3,13) = 3.58, p b 0.05),
Guilt (from M= 2.63, SD = 1.41, to M = 1.69, SD = 1.25; F (3,13) =
5.12, p b 0.01), and Unusual Thought Content (from M = 2.75, SD =
0.78, to M= 1.88, SD = 1.02; F (3,13) = 3.43, p b 0.05).
3.2. Reasons for cannabis reduction/cessation
Three themes were identiﬁed: mental health, social relationships/
connection and lifestyle change. These themes are summarised in
Table 2.
The understanding of the negative psychological consequences asso-
ciated with ongoing cannabis use on a range of levels was highlighted
by participants.Worsening of mental healthwas identiﬁed as a key mo-
tivator for ceasing cannabis, particularly relating to negative experi-
ences from using cannabis and the worsening of psychiatric symptoms:
Well I just had this unpleasant experience… I was just scared and
like I don't want to end up back in hospital. - I thought people were
out to get me… Just trying to sort out my mental health issues.
[(P14)]A realisation that cannabis did not helpwith emotional difﬁculties or
was inconsistent with key values or goals (internal conﬂict) was also
commonly reported:
Table 3
Motivators, effective strategies for reduction or cessation and relapse contexts of cannabis
use.
Motivators Strategies Relapse
Worsening mental health Psychological strategies Substance using
peers
Social relationships/connections Relationship/connection Difﬁculties in
relationships
Lifestyle change Social related changes Coping with
difﬁcult emotionsMedication
34 S. Rebgetz et al. / Addictive Behaviors Reports 4 (2016) 31–36I realised that it wasn't helping me, the hurt was still there when I
was sober… (P5)
I just saw that my life wasn't going anywhere… (P11)
Receiving medication or other treatment, or being hospitalised also
played a role:
…Well itwaswhen I came into hospital….Well I have been linked in
with a case manager. They are helping me sort out my head. I have
the psychiatrist to see…. Well they have me on this medication al-
so… (P14)
The second theme related to social relationships. Social contexts and
relationships are clearly important in the recovery of substance use. Let-
ting others down was mentioned by participants:
Because it was horrible, I thought I was going to die and not be able
to continue to supportmy partner. He is in awheelchair. I felt I could
not leave him, you know what would happen to him if I was to die.
(P1)
Trusting others was identiﬁed by this participant as important:
Well it was sort to dowith trusting people. I have difﬁculties trusting
people and this causes difﬁculties in my relationship with my part-
ner. Just help with that, you know… (P1)
Having support from others and a change of social network were
also seen as important:
Mymum came and sawme and I met some nice people. The staff on
the ward were really kind to me also. I just thought I would try and
give it a go…. I just didn't want it to keep messing with my head. I
wanted to try and stay clean so I could have a relationship with
mum, try and make some new friends…. Yes, just trying to be a bit
more social. (P20)
Another common reason for cannabis cessation/reductionwas relat-
ed to lifestyle change. Participants reported that engaging in education/
employment and ﬁnances triggered changes in their use potentially by
providing an alternate to using substances and giving meaning in their
daily lives:
I was just having trouble with work. Mymindwas all over the place.
I just didn't think it was helping anymore. (P16)
It sort of stopped me doing things also like having the motivation to
get to work. (P7)
I say to myself don't do it you cannot afford it. There are things you
need to spend your money on like my son. (P11)
These themes point to the ability to manage psychological difﬁcul-
ties and a strong emphasis on the role of external factors in the decision
to make a change in ones cannabis use. For example Participant 2
reported:
…I had this admission to hospital where I met you the ﬁrst time. I
thought I was going crazy and the voices were telling me to take
all my medication…. the voices became worse” and “I felt really
guilty that I was stufﬁng up my children's lives…I just saw the im-
pact it was having onmy children. I didn't realise howmuch it affect-
ed them. I have stuffed up their lives and I didn't know howmuch…
Also about mymum's health and I feel like I have stuffed up her life.
Importantly it is likely that a combination of motivators is required
for a person to make an effective change and the realisation of theseverity of the consequences of substance use experienced by partici-
pants. This was highlighted by a number of participants. For example
Participant 5 reported:
I realised that it wasn't helping me, the hurt was still there when I
was sober… Well with my parents, it was mainly my Dad. I think
they knew I smoked but I didn't want to have to admit it to him
and be a disappointment to him… Not really. I guess I wasn't hang-
ing out with the same people and I used to smoke with my ex, so it
was different. I was trying to study also and I don't think it was help-
ing me out there.
Participant 7 said:
I just didn't want to feel that way anymore…. Not really it was just
getting depressed and I don't reckon the weed was helping me. I
think it made me more emotional also… Well I thought if I quit
smoking weed I might feel better. I guess I also didn't want to let
my mum down. My mum also tells me to get to work. Mum doesn't
like me just lying around the house. It sort of stopped me doing
things also like having the motivation to get to work. Well I have
had a bit more motivation. I still feel weird but I am trying to go to
work.
3.3. Strategies for maintaining cannabis cessation
Strategies participants used to maintain cannabis cessation/reduc-
tion were ordered into four themes: psychological strategies, relation-
ship/connection, social related changes, and medication (Table 3).
Awide range of psychological strategieswas employed, with a variety
of strategies likely needed for effective change. A common cognitive
strategy was for participants to reﬂect on past negative experiences
and the effect on their mental illness:
The fear of having an unpleasant experience and the cops coming
around again stopsme fromusing. I'mworried about having another
breakdown and getting locked up. (P14)
Trying to think about how the pot affects my mental illness. (P2)
For these two participants' motivators for cessation included nega-
tive experience andworsening ofmental health symptoms. Themotiva-
tors for change were clearly linked with ongoing effective maintenance
strategies.
Other psychological strategies included emotional change:
Just tried not to feel bad and think of not wanting to feel bad again.
Realising that smoking weed probably wouldn't help and I would
feel guilty afterwards anyway which would make me feel bad. (P7)
Self-belief and self-talk were also seen as important:
Well I just have to get through it. Just telling myself ‘no’. It is easy to
go back and use. (P11)
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breathing, exercising and engaging in other distracting activity. Having
a plan appeared to be an important factor:
Just bymaking sure I had a plan ofwhat Iwas going to say if I ran into
them. Have an excuse that I was busy. (P18)
Relationships played a role in helping participants stay in control, and
included the ability to trust others, getting support from others and
thinking of others:
Being able to trust them and not feel badwhen I need timeout…. my
partner helps me…. I speak with my mum… I think of the kids. I
don't want to stuff them up even more… think about how much I
have already messed the kids up. (P2)
Changing their social network or lifestyle, and takingmedication (e.g.,
antipsychotics) were cited as other ways participants stayed in control.
For participants to stay in control, the realisation that any short-term
relief from cannabis was outweighed by more positive outcomes was
important. An example was provided by Participant 5 who reported:
Well I just felt like I couldn't be by myself. I felt that if I smoked it
would be easier. But I knew that it wasn't going to make it better,
I'd feel the same the next day. Anyways I had gotten past the addic-
tion so I just had to keep off it.
Manymaintenance strategies identiﬁed by participantswere similar
to the initial reasons for change. An example is provided by Participant 1
who reported an initial reason as: I had this negative experience where
after having bongs I collapsed to the ﬂoor. I was really scared and I was
never going to use again as a result.And maintenance strategies as:
Thinking about that time when I collapsed on the ﬂoor. I never want
that shit to happen again. It really freaked me and my partner out.
3.4. Relapse
Only 3 of the 11 interviewed participants who ceased cannabis use
altogether reported a relapse (a return to using cannabis). Their ac-
counts identiﬁed the presence of substance using peers, difﬁculties in
relationships and coping with difﬁcult emotions related to past trauma,
depressed or lonely feelings as triggers for this relapse:
I was just lonely, my family are not around and I don't have any
friends so I just started smoking again…. Just as a comforter, rather
than thinking about my childhood. Just to shut my body down for
a bit, stop having to deal with it all. (P20)
For those participants that relapsed there appeared to be less em-
phasis on social aspects in their reported effective maintenance strate-
gies and relationship difﬁculties and associated negative emotions
played a role in relapse.
4. Discussion
This qualitative prospective study explored natural recovery from
cannabis use among people with early psychosis over 3months. Con-
sistent with previous research, worsening mental health symptoms
were identiﬁed as a major reason for reducing/ceasing cannabis use
(Rebgetz, Hides, et al., 2015; Rebgetz, Kavanagh, et al., 2015). Rela-
tionship issues were identiﬁed as another major reason for making
a change in cannabis use—particularly concerns about letting others
down. While these issues appeared to be powerful motivators for
change, a focus on past difﬁculties may undermine self-efﬁcacy and
coping. Focusing users' attention on instances where they main-
tained control of cannabis use and fulﬁlled their responsibilities
may allow these concerns to sustain a control attempt without trig-
gering distress and hopelessness.Relationships with others were also identiﬁed as key motivator
for maintaining cannabis reduction/cessation. Maisto, Carey, Carey,
Purnine, and Barnes (1999), also found the receipt of emotional
and practical support was a key therapeutic factor in reasons for
change for substance use disorder in schizophrenia. Treatments fo-
cused on developing and maintaining healthy relationships could
help to reduce the use of illicit drugs to cope with problematic at-
tachments (Alexander, 2008).
An important ﬁnding of the current study was the breath and se-
verity of the adverse substance use consequences experienced by
participants. As we identiﬁed in our recent review (Rebgetz,
Kavanagh, et al., 2015), the psychotic symptoms, distress, narrowing
of social networks and activities and poverty that are experienced by
people with psychosis, renders this group particularly susceptible to
negative effects of substance use on relationships, discretionary in-
comes, activities and wellbeing. The negative nature of some of
these experiences is likely to amplify motivation to reduce cannabis
use, to the extent seen among more extreme substance users in the
general population (which may help to explain the frequency of
their attempts to control use, even when the amounts consumed
are relatively small). Among these impacts were ﬁnancial and em-
ployment-related reasons for change, which have also been identi-
ﬁed in previous research (Rebgetz, Kavanagh, et al., 2015).
Emphasising the negative effects of cannabis on multiple life do-
mains may maximise the chance that people with psychosis will
begin an attempt to control cannabis use and may offer a key to suc-
cessful control (Green, Yarborough, Polen, Janoff, & Yarborough,
2015).
While distress about these issuesmay bemotivating, difﬁculties deal-
ing with distress more generally constituted a perceived risk for control,
as did the limited range of coping mechanisms they appeared to have
to cope with it. In common with dysfunctional substance use in other
contexts, maintenance of control required relinquishing any short-term
relief from cannabis in favour of more positive distal outcomes. Where
peoplewith psychosis have experienced trauma,maintaining control de-
spite negative emotions may be particularly challenging. Links between
lifetime cannabis consumption, childhood abuse and psychosis are well
documented (Houston, Murphy, Adamson, Stringer, & Shevlin, 2008;
van Dam et al., 2015). There were some indications in the current study
that trauma may be important, particularly in relation to relapse, but as
only three participantswith a traumahistory reported a relapse, these re-
sultsmust be viewedwith caution. Examination of relationships between
trauma and relapse in a larger study may clarify the extent of its role.
Our results are consistent with previous research on relapse in sub-
stance users fromboth the general population and in peoplewith serious
mental disorders (Rebgetz, Hides, et al., 2015). They also support relapse
models of substance use that highlight the interaction between situa-
tional risk factors and individual characteristics (Anderson, Frissell, &
Brown, 2007), and emphasise the need to develop strategies for emotion
regulation as an important component of treatments. Schema therapy
may also assist, given emerging evidence on its application to substance
use by people with personality disorders (Kellogg & Tatarsky, 2012).
This study explicitly distinguished between strategies that may as-
sist with initiating reduction or cessation from those involved in main-
taining it. We previously identiﬁed a number of strategies that could
support users at both stages (Rebgetz, Kavanagh, et al., 2015). Psycho-
logical strategies (rememberingnegative experience; self-belief; behav-
ioural change; effect on mental illness), social reinforcement related to
family and signiﬁcant others, lifestyle change and using medication
were the main factors which respondents said had helped them stay
in control. However, there was a limited range of coping strategies to
control use, and these strategies tended to be relatively basic (e.g. escap-
ing a high-risk situation, rather than being able to deal with the risk).
Implications include the importance of ensuring that treatments focus
on behavioural rather than cognitive strategies, and on ones that are
both readily trained and likely to be effective.
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cannabis users with psychosis to qualitatively explore - the initiation of
cannabis cessation, strategies to maintain abstinence, and risk factors
for relapse in cannabis use. While there were many similarities in the
themes relating to these contexts, the emergence of some key differ-
ences in responses suggests that treatment approaches may need to
emphasise different aspects at each point in the recovery journey. The
use of psychological approaches that address emotional issues including
any past trauma may be particularly important for relapse prevention.
Limitations of this study include relatively small group of purposive-
ly sampled participants. However, recruitment continued until no new
themes emerged, which suggests that a larger sample was unlikely to
identify additional themes. As all participants were inpatients at the
time of recruitment and were under the care of outpatient case man-
agers from their local mental health services during follow up, it is pos-
sible that their responses may have been inﬂuenced by their
interactions with staff or patients (e.g. reﬂecting staff opinions of key
factors and effective strategies), which were not recorded on ﬁle. Only
one ﬁle mentioned “psychoeducation for psychosis and substance
use”. While no such interactions were reported as a motivator or main-
tenance strategy during the qualitative interviews, results of the current
study should be conﬁrmed in a community sample with less service ex-
posure. Biases relating to the research team's knowledge of and theoret-
ical adherence to CBT and MI were considered, but that may not have
been sufﬁcient to avert an inﬂuence from those perspectives on the per-
ceived themes. The perceptions of respondents were potentially affect-
ed by the order of questions and by repeated questioning over time. It is
also likely that tracking cannabis use may have inﬂuenced participants'
decisions in regards to ongoing substance use. Future research could
minimise these risks by using respondent validation and applying expe-
rience sampling ormixedmethods (e.g.with a sufﬁcient sample to com-
pare themes within subgroups that have varying mental health
symptoms, stress, and motivation).
4.1. Conclusion
Increasing people's awareness of the adverse impact of cannabis use
across multiple life domains may be critical to cannabis cessation and
maintenance of change, both in order to maximise motivation, and to
avoid over-dependence on one life area. Development of a range of cop-
ing strategies to manage stress, alleviate boredom and deal with pres-
sure from substance-using peers also appears important, if users are to
effectivelymeet these common challenges. Focusing on emotion regula-
tion and developing andmaintaining healthy relationships appear to be
areas worthy of particular additional exploration.
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